We are asking you to book profits on this Prime Stock that was an underperformer for a while but has quickly delivered returns.
Prime Stocks update: Book profits in this energy stock Read More »
Results Update for 8 of our Prime Stocks.
Results update 1 for quarter ending December 2023 Read More »
A correction in the stock price of HDFC Bank prompted many of you to ask whether it was an opportunity to buy. Here is your answer!
HDFC BANK: Buy, Hold or Sell? Read More »
How we see equity markets behaving over the course of 2024.
Prime Equity Outlook 2024 Read More »
A sharp rally resulting in rich valuations have prompted us to move this auto ancillary stock to a ‘HOLD’.
Prime Stock update – A shift to Hold for this auto ancillary company Read More »
A review of Pulak Prasad’s book – What I learned about investing from Darwin.
Book review: Unlocking Nalanda Capital’s best guarded investment formula Read More »
A year-end review of Prime Stocks performance and how our calls have fared against the market.
Prime Stocks performance review 2023 Read More »
With the markets hitting fresh highs, should we be celebrating or are we in a market bubble that is getting dangerously big?
5 signs of a brewing market bubble Read More »
Should you invest in the Rs. 960 crore Muthoot Microfin IPO? Find out in this detailed review.
Muthoot Microfin IPO: Should you invest? Read More »
A guide to understanding how regulatory risks can affect your stock investments and few ideas on how you can navigate.
Regulatory risks in stock investing – a guide Read More »
A highly unorganized sector with a huge addressable opportunity and consolidation potential. Play it with this diagnostic stock!
Prime Stock recommendation: A diagnostic stock for the long term Read More »
An update on the sugar stock that we have a ‘BUY’ call on in the wake of the curbs placed on manufacture of ethanol in the 23-24 season.
Prime stock alert: Update on our sugar stock recommendation Read More »
The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research services before onboarding. History, Present business and Background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services. Terms and conditions of Research Services: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Analyst never guarantees the returns on the recommendation provided. Investor shall take note that Investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The Research Analyst shall not be responsible for any loss to the Investors. Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made there under against the Research Analyst relating to Research Analyst services. Details of its associates: No associates. Disclosures with respect to Research and Recommendations Services: The Research Analyst or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of Research Analyst services. Such conflict of interest shall be disclosed to the client as and when they arise. Research Analyst or its directors or its employee or its associates have not received any compensation from the company which is subject matter of recommendation. Research Analyst or its directors or its employee or its associates have not managed or co-managed the public offering of any company. Research Analyst or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation. The subject company was not a client of Research Analyst or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided. Research Analysts or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.
Full disclosures and disclaimers
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
